Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
R. Jacob Vogelstein currently holds 20,300 shares of Iambic Therapeutics, Inc. (IAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, R. Jacob Vogelstein has been a net neutral trader of IAM stock. They have purchased $0 and sold $0 worth of shares.
R. Jacob Vogelstein's most recent insider trade was on Oct 14, 2026, when they sold 20,300 shares at $0.00 per share.
R. Jacob Vogelstein serves as Executive at Iambic Therapeutics, Inc. (IAM). They have executed 1 insider transactions totaling $0 over their tenure at the company.
R. Jacob Vogelstein holds the position of Executive at Iambic Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
R. Jacob Vogelstein has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by R. Jacob Vogelstein was on Oct 14, 2026, when they purchased $0 worth of IAM shares. This transaction involved 20,300 shares at N/A per share.
R. Jacob Vogelstein currently owns 20,300 shares of Iambic Therapeutics, Inc. (IAM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of R. Jacob Vogelstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. R. Jacob Vogelstein has 1 Form 4 filings on record as an insider at Iambic Therapeutics, Inc..
Set alerts for R. Jacob Vogelstein and 40,000+ other insiders.